The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...

The ongoing conflicts between Ukraine and Russia, as well as Israel and Palestine, have sent ripples across various ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

A Nigerian pharmaceutical company, ST. RACHEAL’S Pharma, has urged President Bola Tinubu to ensure the return of all ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...